Authors: Sandmair, AM Loimas, S Puranen, P Immonen, A Kossila, M Puranen, M Hurskainen, H Tyynela, K Turunen, M Vanninen, R Lehtolainen, P Paljarvi, L Johansson, R Vapalahti, M Yla-Herttuala, S

Citation: Am. Sandmair et al., Thymidine kinase gene therapy for human malignant glioma, using replication-deficient retroviruses or adenoviruses, HUM GENE TH, 11(16), 2000, pp. 2197-2205

Authors: Sandmair, AM Turunen, M Tyynela, K Loimas, S Vainio, P Vanninen, R Vapalahti, M Bjerkvig, R Janne, J Yla-Herttuala, S

Citation: Am. Sandmair et al., Herpes simplex virus thymidine kinase gene therapy in experimental rat BT4C glioma model: Effect of the percentage of thymidine kinase-positive glioma cells on treatment effect, survival time, and tissue reactions, CANC GENE T, 7(3), 2000, pp. 413-421

Authors: Sandmair, AM Vapalahti, M Yla-Herttuala, S

Citation: Am. Sandmair et al., Adenovirus-mediated herpes simplex thymidine kinase gene therapy for braintumors, ADV EXP MED, 465, 2000, pp. 163-170

Authors: Sandmair, AM Vapalahti, M Yla-Herttuala, S

Citation: Am. Sandmair et al., Adenoviruses as gene delivery vectors, ADV EXP MED, 465, 2000, pp. 423-429

Authors: Hakumaki, JM Poptani, H Sandmair, AM Yla-Herttuala, S Kauppinen, RA

Citation: Jm. Hakumaki et al., H-1 MRS detects polyunsaturated fatty acid accumulation during gene therapy of glioma: Implications for the in vivo detection of apoptosis, NAT MED, 5(11), 1999, pp. 1323-1327

Authors: Sandmair, AM Loimas, S Poptani, H Vainio, P Vanninen, R Turunen, M Tyynela, K Vapalahti, M Yla-Herttuala, S

Citation: Am. Sandmair et al., Low efficacy of gene therapy for rat BT4C malignant glioma using intra-tumoural transduction with thymidine kinase retrovirus packaging cell injections and ganciclovir treatment, ACT NEUROCH, 141(8), 1999, pp. 867-872